KCNJ11 and chronic obstructive pulmonary disease: To sum up, the MR analysis indicates a potential cause-and-effect connection between KCNJ11 and DPP4 inhibitors and COPD risk, recommending that clinical trials should be conducted to investigate whether antidiabetic drugs offer protective benefits against COPD.